1. Academic Validation
  2. Developing potent human uric acid transporter 1 (hURAT1) inhibitors

Developing potent human uric acid transporter 1 (hURAT1) inhibitors

  • J Med Chem. 2011 Apr 28;54(8):2701-13. doi: 10.1021/jm1015022.
Michael F Wempe 1 Promsuk Jutabha Bettina Quade Timothy J Iwen Morin M Frick Ian R Ross Peter J Rice Naohiko Anzai Hitoshi Endou
Affiliations

Affiliation

  • 1 School of Pharmacy, University of Colorado Anschutz Medical Campus, Aurora, Colorado 80045, United States. Michael.Wempe@ucdenver.edu
Abstract

The kidneys are a vital organ in the human body. They serve several purposes including homeostatic functions such as regulating extracellular fluid volume and maintaining acid-base and electrolyte balance and are essential regarding the excretion of metabolic waste. Furthermore, the kidneys play an important role in uric acid secretion/reabsorption. Abnormalities associated with kidney transporters have been associated with various diseases, such as gout. The current study utilized Xenopus oocytes expressing human uric acid transporter 1 (hURAT1; SLC22A12) as an in vitro method to investigate novel compounds and their ability to inhibit (14)C-uric acid uptake via hURAT1. We have prepared and tested a series of 2-ethyl-benzofuran compounds and probed the hURAT1 in vitro inhibitor structure-activity relationship. As compared to dimethoxy analogues, Monophenols formed on the C ring showed the best in vitro inhibitory potential. Compounds with submicromolar (i.e., IC(50) < 1000 nM) inhibitors were prepared by brominating the corresponding Phenols to produce compounds with potent uricosuric activity.

Figures
Products